Perampanel

Fycompa (perampanel) is a prescription medication that acts as a noncompetitive AMPA glutamate receptor antagonist to help control seizures in epilepsy patients. Available as oral tablets in strengths from 2mg to 12mg, it's manufactured by Catalyst Pharmaceuticals, Inc., and is a Schedule III controlled substance. This information was generated using AI and is provided for informational and research purposes only.